Development and Validation of a New Gas Chromatography–Tandem Mass Spectrometry Method for the Measurement of Enrichment of Glyoxylate Metabolism Analytes in Hyperoxaluria Patients Using a Stable Isotope Procedure
Dewi van Harskamp(Emma Kinderziekenhuis), Henk Schierbeek(Emma Kinderziekenhuis), Jaap W. Groothoff(University of Amsterdam), Michiel J.S. Oosterveld(Emma Kinderziekenhuis), Johannes B. van Goudoever(Emma Kinderziekenhuis), Sander F. Garrelfs(Emma Kinderziekenhuis)
Cited by 12
Related Papers
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
|New England Journal of Medicine|2021|505
Nutrition During Pregnancy, Lactation and Early Childhood and its Implications for Maternal and Long-Term Child Health: The Early Nutrition Project Recommendations
|Annals of Nutrition and Metabolism|2019|413
Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment
|Nephrology Dialysis Transplantation|2012|335
Clinical practice recommendations for primary hyperoxaluria: an expert consensus statement from ERKNet and OxalEurope
|Nature Reviews Nephrology|2023|154
Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria
|Nephrology Dialysis Transplantation|2011|144